Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Dividends

Explore dividend yields, payout ratios, and historical trends to maximize your investment strategies.

OBIO

Orchestra BioMed Holdings Inc

May 24 • 04:00PM ET

5.30

Dollar change +0.08
Percentage change 1.53	%

Healthcare • Biotechnology • USA • NASD

Chart Stock Detail • Compare Perf. • Revenue • Dividends • Options Options Chain • Save to Portfolio • Create Alert

Held by: VTI VXF IWM IWO SCHA VTWO IWC SCHB VTWG RYLD

Scroll to Statements

Index	RUT	P/E	-	EPS (ttm)	-1.46	Insider Own	42.43%	Shs Outstand	35.78M	Perf Week	1.73%
Market Cap	189.69M	Forward P/E	-	EPS next Y	-1.69	Insider Trans	0.00%	Shs Float	20.61M	Perf Month	19.37%
Income	-51.64M	PEG	-	EPS next Q	-0.40	Inst Own	36.48%	Short Float	4.04%	Perf Quarter	-15.74%
Sales	2.22M	P/S	85.44	EPS this Y	-7.06%	Inst Trans	-31.90%	Short Ratio	20.94	Perf Half Y	-11.22%
Book/sh	1.60	P/B	3.32	EPS next Y	-6.82%	ROA	-47.18%	Short Interest	0.83M	Perf Year	-64.90%
Cash/sh	2.10	P/C	2.53	EPS next 5Y	-	ROE	-65.81%	52W Range	4.22 - 17.35	Perf YTD	-41.95%
Dividend Est.	-	P/FCF	-	EPS past 5Y	-	ROI	-88.51%	52W High	-69.45%	Beta	0.27
Dividend TTM	-	Quick Ratio	7.33	Sales past 5Y	-7.29%	Gross Margin	75.07%	52W Low	25.59%	ATR (14)	0.42
Dividend Ex-Date	-	Current Ratio	7.34	EPS Y/Y TTM	-160.83%	Oper. Margin	-2454.15%	RSI (14)	55.76	Volatility	8.55% 8.79%
Employees	56	Debt/Eq	0.03	Sales Y/Y TTM	90.38%	Profit Margin	-2330.46%	Recom	1.00	Target Price	16.33
Option/Short	No / Yes	LT Debt/Eq	0.02	EPS Q/Q	4.93%	Payout	-	Rel Volume	0.88	Prev Close	5.22
Sales Surprise	-34.74%	EPS Surprise	4.28%	Sales Q/Q	-46.74%	Earnings	May 13 AMC	Avg Volume	39.81K	Price	5.30
SMA20	7.81%	SMA50	7.28%	SMA200	-17.55%	Trades		Volume	35,077	Change	1.53%

Date	Action	Analyst	Rating Change	Price Target Change
Jan-19-24	Initiated	Jefferies	Buy	$14
Feb-24-23	Initiated	Piper Sandler	Overweight	$15
Feb-07-23	Initiated	Chardan Capital Markets	Buy	$20

May-22-24 08:43AM	Orchestra BioMed to Participate in Jefferies Global Healthcare Conference (GlobeNewswire)
May-13-24 09:53PM	OBIO Stock Earnings: Orchestra BioMed Hldgs Beats EPS, Misses Revenue for Q1 2024 (InvestorPlace)
06:05PM	Orchestra BioMed Holdings, Inc. (OBIO) Reports Q1 Loss, Misses Revenue Estimates (Zacks)
04:58PM	Orchestra BioMed Reports First Quarter 2024 Financial Results and Provides a Business Update (GlobeNewswire)
Apr-30-24 08:30AM	Orchestra BioMed Announces AVIM Therapy Global Intellectual Property Estate Reaches 110 Issued Patents (GlobeNewswire)
08:00AM	Loading…
08:00AM	Orchestra BioMed to Host In-Person R&D Day in New York on AVIM Therapy Program in Hypertensive Pacemaker Patients on June 11, 2024 (GlobeNewswire)
Mar-27-24 04:17PM	Orchestra BioMed Reports Full Year 2023 Financial Results and Provides Fourth Quarter Business Update (GlobeNewswire)
Mar-26-24 08:00AM	Orchestra BioMed Announces Appointment of Medical Device Industry Expert David Pacitti to Board of Directors (GlobeNewswire) +5.20%
Mar-13-24 08:00AM	Orchestra BioMed Demonstrates Strength of Cardiovascular Pipeline with Virtue SAB and AVIM Therapy Presentations at CRT 2024 Annual Meeting (GlobeNewswire)
Mar-07-24 08:00AM	Orchestra BioMed to Participate in Upcoming Investor Conferences (GlobeNewswire) -6.62%
Mar-06-24 08:37AM	Orchestra BioMed Announces Presentation of Results from Clinical Study Demonstrating Favorable Hemodynamic Effects of AVIM Therapy In Hypertensive Pacemaker Patients (GlobeNewswire)
Feb-26-24 08:00AM	Orchestra BioMed Presents New Data Showing Sustained Clinically Meaningful Reduction in 24-Hour Ambulatory Systolic Blood Pressure in Hypertensive Pacemaker Patients Treated with AVIM Therapy for Over 3 Years (GlobeNewswire)
Feb-16-24 09:13AM	Why Orchestra BioMed (OBIO) Might Surprise This Earnings Season (Zacks) -8.45%
Jan-08-24 07:30AM	Orchestra BioMed Announces Initiation of BACKBEAT Pivotal Study of AVIM Therapy in Hypertensive Pacemaker Patients (GlobeNewswire) +9.38%
Nov-13-23 04:21PM	Orchestra BioMed Reports Third Quarter 2023 Financial Results and Provides Business Update (GlobeNewswire) +14.61%
04:42PM	Loading…
Nov-09-23 04:42PM	Orchestra BioMed to Present at Upcoming Investor Conferences (GlobeNewswire)
Oct-30-23 03:52PM	Billionaire Marc Lasrys Top 10 Stock Picks (Insider Monkey)
Sep-22-23 11:27AM	Lab Notes: Main Line firm spins off company that will focus on OTC product pipeline (American City Business Journals)
Sep-19-23 02:37PM	Rebel's Edge - September 19: $NIO, $BHC, $OBIO, and the Firing of MSU's Football Coach (TheStreet.com) +27.61%
07:30AM	Orchestra BioMed Granted FDA Approval of IDE to Initiate BACKBEAT Pivotal Study of BackBeat CNT for the Treatment of Hypertension in Pacemaker Patients (GlobeNewswire)
Sep-06-23 05:00PM	Motus GI Appoints Medical Device Industry Veteran Scott Durbin to its Board of Directors (GlobeNewswire)
Aug-10-23 04:34PM	Orchestra BioMed Reports Second Quarter 2023 Financial Results and Provides Business Update (GlobeNewswire) +7.05%
Aug-08-23 08:30AM	Orchestra BioMed Granted FDA Approval of IDE for U.S. Pivotal Study of Virtue® Sirolimus AngioInfusion Balloon in Patients with Coronary In-Stent Restenosis (GlobeNewswire)
Jul-27-23 09:47AM	Orchestra BioMed Holdings, Inc. (NASDAQ:OBIO) stock most popular amongst retail investors who own 36%, while hedge funds hold 28% (Simply Wall St.) -14.00%
Jun-28-23 02:16PM	Why Shares of Orchestra BioMed Holdings Jumped Wednesday (Motley Fool) +24.85%
Jun-26-23 08:00AM	Orchestra BioMed Set to Join Russell 3000® and other FTSE Russell Indexes (GlobeNewswire) -9.81%
Jun-07-23 08:30AM	Orchestra BioMed Appoints Bill Little as Executive Vice President of Corporate Development and Strategy and Andrew Taylor as Chief Financial Officer (GlobeNewswire) -6.42%
Jun-01-23 08:00AM	Orchestra BioMed to Present at the Jefferies Global Healthcare Conference (GlobeNewswire) +8.93%
May-12-23 09:15AM	Orchestra BioMed Reports First Quarter 2023 Financial Results and Provides Business Update (GlobeNewswire)
Apr-11-23 05:39AM	3 Stocks That Already Doubled in 2023 and Could Keep Climbing (Motley Fool) +10.12%
06:05AM	Loading…
Mar-27-23 06:05AM	Orchestra BioMed Holdings Full Year 2022 Earnings: US$14.60 loss per share (vs US$10.90 loss in FY 2021) (Simply Wall St.)
Mar-24-23 03:52PM	Why Shares of Orchestra BioMed Jumped This Week (Motley Fool)
Mar-07-23 08:00AM	Orchestra BioMed to Present at Upcoming Investor Conferences (GlobeNewswire) -6.77%
Feb-24-23 08:00AM	Orchestra BioMed Announces Upcoming Presentations on BackBeat CNT and Virtue® SAB at CRT 2023 (GlobeNewswire)
Feb-07-23 08:00AM	Orchestra BioMed Strengthens Senior Leadership Team (GlobeNewswire)

Orchestra Biomed Holdings, Inc. engages in the provision of biomedical technologies to patients through risk-reward-sharing partnerships with medical device companies. The company was founded on May 25, 2020 and is headquartered in New Hope, PA.

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

OBIO

Orchestra BioMed Holdings Inc

Upgrade your FINVIZ experience